2nd Quarter - Report

BECTON, DICKINSON AND COMPANY for BECTON DICKINSON AND COMPANY

Firm
Client
Income
—
Expenses
$200,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

6 issue areas, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

Issues related to device cybersecurity

LobbyistCovered position, as disclosed
TODD SPANGLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Trade (domestic/foreign) TRD

India price controls

LobbyistCovered position, as disclosed
TODD SPANGLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Issues related to medical technology regulation Issues related to antimicrobial resistance Issues related to hazardous drug safety

LobbyistCovered position, as disclosed
JESSICA JOHNSTON —
JENNIFER M LURAY —
DANNY LY —
TODD SPANGLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

NIH Funding Global Health Funding

LobbyistCovered position, as disclosed
JENNIFER M LURAY —
DANNY LY —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Medicare/Medicaid MMM

Issues related to updating the medical claims form

LobbyistCovered position, as disclosed
TODD SPANGLER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

H.R.184, Protect Medical Innovation Act of 2017 Issues related to corporate tax

LobbyistCovered position, as disclosed
JESSICA JOHNSTON —
JENNIFER M LURAY —
DANNY LY —
TODD SPANGLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 184 (115th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.